Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BRIEF-Progressive Care - Booked About $160,000 In Revenues Related To Rapid Results Covid-19 Virus Testing In Nov, Up 72% On Month-Over-Month Basi
Progressive Care Announces November 2020 Results, Reports Strong Prescriptions and Covid-19 Rapid Testing Sales
BY GlobeNewswire
— 7:00 AM ET 01/08/2021
MIAMI, FL, Jan. 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. ( RXMD
Loading...
Loading...
) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the month of November 2020.
• Consolidated gross sales across all locations during November 2020 totaled $3.4 million, representing a 6.3% year-over-year growth when compared with November 2019.
• Prescriptions filled during November came in at approximately 42,600, which was roughly flat (down less than 1%) on a year-over-year basis.
• 340B fees grew 94% in November on a year-over-year basis, to approximately $212,000.
• The Company booked approximately $160,000 in revenues related to Rapid Results COVID-19 Virus Testing in November, up 72% on a month-over-month basis.
“While this remains a challenging environment for our clients, patients and providers, we continue to execute at a high level, and we are grateful for the opportunity to provide value for our surrounding communities,” commented Alan Jay Weisberg, CEO and Chairman of Progressive Care ( RXMD
Loading...
Loading...
). “Overall sales continued to demonstrate a robust growth trend, our testing and TPA services surged once again, and we look forward to further growth opportunities in the months and quarters ahead given our recent physical consolidation, our upcoming Orlando, Florida expansion, and the strong logistical foundations we have laid for both the launch of Covid-19 vaccine administration and further robust growth in our COVID-19 testing services.”
The Company has also recently completed a move into its new 11,000 sq ft pharmacy space in Hallandale Beach, Florida and plans to complete the move to its new 3,700 sq ft Orlando location before the end of January, which should drive important performance gains, advances in productivity, volume, and market reach due to the space and efficiency.
“Our expanded Orlando location represents a major upgrade,” added Weisberg. “In addition to driving gains in our access to the dynamic Orlando market, the move will allow us to build out our growing 340B business and dramatically expand our rapid results testing services.”
For more information about Progressive Care ( RXMD
Loading...
Loading...
), please visit the company’s website. Connect and stay in touch with us on social media:
Progressive Care Inc. ( RXMD
Loading...
Loading...
)
Progressive Care Completes Move to New Facility, Begins Expansion Into Long-Term Care Pharmacy Market
BY GlobeNewswire
— 7:00 AM ET 12/23/2020
Miami, FL, Dec. 23, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. ( RXMD
Loading...
Loading...
) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company has completed its move into its new 11,000 sq ft pharmacy space in Hallandale Beach, FL.
In addition to the cost savings, management believes the move will also drive advances in productivity, volume, and market reach due to the space and efficiency afforded by the Hallandale Beach location.
“The new location is positioned and designed to access the South Florida long-term care pharmacy marketplace across five of the highest LTC-concentration counties in the U.S. prescription market,” commented Alan Jay Weisberg, CEO and Chairman of Progressive Care ( RXMD
Loading...
Loading...
). “In addition to addressing the huge and growing need for prescription medications at long-term care facilities in this region, Progressive Care ( RXMD
Loading...
Loading...
), through its new expanded location, is also committed to becoming a leader in the rapidly growing Infusion therapy market, a logistically advantageous expansion that stands to have a material and durable impact on both volume and margins in our core pharmacy business.”
According to a recent research report from Access Market Intelligence, the long-term care pharmacy market was nearly $17 billion in 2019 on more than 400 million prescriptions filled.
For more information about Progressive Care ( RXMD
Loading...
Loading...
), please visit the company’s website. Connect and stay in touch with us on social media:
Progressive Care Inc. ( RXMD
Loading...
Loading...
)
Progressive Care Announces October Growth in Net Revenues as COVID-19 Testing Ramps Up
BY GlobeNewswire
— 7:00 AM ET 12/07/2020
MIAMI, FL, Dec. 07, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. ( RXMD
Loading...
Loading...
) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the month of October, which featured a strong jump in operating margins, significant sequential monthly growth in net revenues, and the establishment of sales growth related to rapid results COVID-19 testing.
Consolidated net sales across all locations during October 2020 totaled $3,3M, representing a 7% sequential monthly growth.
October margins increased to 27%, helping to drive a 53% sequential monthly jump in cash on hand.
Prescriptions filled during October grew 1% on a sequential monthly basis.
340B pharmacy dispensing fees grew 119% in October on a year-over-year basis.
The Company booked nearly $100K in revenues related to rapid results COVID-19 testing in October.
Management notes that gross sales saw a minor drop, driven by the Company’s aggressive push to prioritize generic medication alternatives over expensive branded medications, which offer savings to customers as well as wider profit margins for the pharmacy.
October was also a significant month as the Company saw its rapid results virus testing service expand substantially. The Company is focused on building the PharmcoRx brand as a solution for COVID-19 rapid testing by adding two new analyzers for PCR Testing: Abbott ID NOW and Cepheid. The Cepheid analyzer will allow the Company to simultaneously test for four types of infections: COVID-19, Flu A, Flu B and RSV, providing rapid results in 15 minutes.
“October was another strong month characterized by expanding margins and strong execution,” commented Alan Jay Weisberg, CEO and Chairman of Progressive Care ( RXMD
Loading...
Loading...
). “We have secured a market-leading position in COVID-19 testing in Dade County and we look forward to becoming a major provider of COVID-19 vaccines next year.”
For more information about Progressive Care ( RXMD
Loading...
Loading...
), please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
Turning back around nicely as we stated earlier............
If those buyers who came in late yesterday return at the same time we should be good here by EOD! Patience.
Perfectly Normal Here. Weak Hands Leaving, Strong Hands Buying!
I see those. The games will over soon and it will go past $.20!
Next Leg Up Coming!
Good Trading So Far!
I believe they have close to 100 employees.
$RXMD opened last week at $.058, closed at $.19!!!!
$RXMD is a UNICORN! Get it between $3 and $5 and uplist to NASDAQ for real gains WITHOUT RS!
The best is yet to come!
* 2020 $40.6M REVENUE, walking the profitability line!
* 2021 will be profitable because of operations consolidations, now complete, and new profit center expansion, IMO.
* CEO letter on 9/16/2020, PR below, mentions organic path to $100M REVENUE!
* S-1 FILED with SEC, confidential to the public, to protect their secret expansion plan.
* $RXMD is in MANDATORY Quiet Period before expected NASDAQ Uplist.
* $RXMD has stated that transformative changes are coming!
* $RXMD is expanding to technology sales, telehealth, and pharmaceutical processing with metrics.
* Many initiatives, and acquisition rumors, see DD links below.
* New EagleForce Health Partnership announced last week, PR below with statement from EagleForce Health included. The $RXMD CEO stated that this partnership will "scale more of our operations in a geographically agnostic manner" (Telehealth Web! National! International?)
* MyApps Partnership benefits both companies by perfecting the CallingDr App, and all RXMD technology implementations, including ClearMetrX. RXMD wanted to acquire MyApps for shares, but the shareholders were vocally unhappy, and RXMD announced a win-win Partnership instead, PR below.
* OS only 485M!
* Market Cap still low at $51M!
* $RXMD is worth $150M if sold Privately, estimated on Telegram by a friend of the founder, and it is easy to justify that number just based on REVENUE, assets, and growth momentum.
* Public company multiple should be at least 3X $450M with current initiatives, perhaps higher because of unknowns in confidential S-1, IMO
* $450M fair valuation puts PPS at $.93! With NASDAQ uplist, M&A rumor, technology expansion, and everything else in the pipeline including organic growth, speculation and momentum could drive PPS much higher, perhaps enough to uplist!! IMO
* OTCQB Member Since 12/2017, Penny Stock Exempt, Transfer Agent Verified, Independent Directors
* No viable trips exist! $RXMD is a UNICORN! If you check it out, you'll see the value!!
RXMD Investor Deck 2021
PR RXMD Telehealth Partnership with EagleForce Health
EagleForce: Interoperability of healthcare... big data
CEO letter to shareholders with path to $100M REVENUE
MyApps Partnership, including CallingDr App and ClearMetrX
$NETE M&A Rumor
INSTATRADER's DD Pack
RXMD Annual Revenue Growth History 2013 - 2020
ProgressiveCareUS.com
PharmCoRx.com
ClearMetrX.com
facebook.com/ProgressiveCareUS
facebook.com/PharmCoRx
facebook.com/ClearMetrX
twitter.com/ProgressCareUS
twitter.com/PharmCoRx
twitter.com/ClearMetrX
otcmarkets.com/stock/RXMD/news
otcmarkets.com/stock/RXMD/disclosure
otcmarkets.com/stock/RXMD/security
investorshub.advfn.com/Progressive-Care-Inc-RXMD-19843
$RXMD has been under attack for years, ever since the former CEO took action to force naked shorts to cover. IMO, it is the only reason that the PPS is so low.
Progressive Care Updates Shareholders on the Status of Naked Shorts
May 1, 2018.
https://www.globenewswire.com/news-release/2018/05/01/1494089/0/en/Progressive-Care-Updates-Shareholders-on-the-Status-of-Naked-Shorts.html
High Speed Trading Firm... going to war with the SEC
Message Board Thread
Good Luck RXMD!
$$$,$$$,$$$
$RXMD opened last week at $.058, closed at $.19!!!!
$RXMD is a UNICORN! Get it between $3 and $5 and uplist to NASDAQ for real gains WITHOUT RS!
The best is yet to come!
* 2020 $40.6M REVENUE, walking the profitability line!
* 2021 will be profitable because of operations consolidations, now complete, and new profit center expansion, IMO.
* CEO letter on 9/16/2020, PR below, mentions organic path to $100M REVENUE!
* S-1 FILED with SEC, confidential to the public, to protect their secret expansion plan.
* $RXMD is in MANDATORY Quiet Period before expected NASDAQ Uplist.
* $RXMD has stated that transformative changes are coming!
* $RXMD is expanding to technology sales, telehealth, and pharmaceutical processing with metrics.
* Many initiatives, and acquisition rumors, see DD links below.
* New EagleForce Health Partnership announced last week, PR below with statement from EagleForce Health included. The $RXMD CEO stated that this partnership will "scale more of our operations in a geographically agnostic manner" (Telehealth Web! National! International?)
* MyApps Partnership benefits both companies by perfecting the CallingDr App, and all RXMD technology implementations, including ClearMetrX. RXMD wanted to acquire MyApps for shares, but the shareholders were vocally unhappy, and RXMD announced a win-win Partnership instead, PR below.
* OS only 485M!
* Market Cap still low at $51M!
* $RXMD is worth $150M if sold Privately, estimated on Telegram by a friend of the founder, and it is easy to justify that number just based on REVENUE, assets, and growth momentum.
* Public company multiple should be at least 3X $450M with current initiatives, perhaps higher because of unknowns in confidential S-1, IMO
* $450M fair valuation puts PPS at $.93! With NASDAQ uplist, M&A rumor, technology expansion, and everything else in the pipeline including organic growth, speculation and momentum could drive PPS much higher, perhaps enough to uplist!! IMO
* OTCQB Member Since 12/2017, Penny Stock Exempt, Transfer Agent Verified, Independent Directors
* No viable trips exist! $RXMD is a UNICORN! If you check it out, you'll see the value!!
RXMD Investor Deck 2021
PR RXMD Telehealth Partnership with EagleForce Health
EagleForce: Interoperability of healthcare... big data
CEO letter to shareholders with path to $100M REVENUE
MyApps Partnership, including CallingDr App and ClearMetrX
$NETE M&A Rumor
INSTATRADER's DD Pack
RXMD Annual Revenue Growth History 2013 - 2020
ProgressiveCareUS.com
PharmCoRx.com
ClearMetrX.com
facebook.com/ProgressiveCareUS
facebook.com/PharmCoRx
facebook.com/ClearMetrX
twitter.com/ProgressCareUS
twitter.com/PharmCoRx
twitter.com/ClearMetrX
otcmarkets.com/stock/RXMD/news
otcmarkets.com/stock/RXMD/disclosure
otcmarkets.com/stock/RXMD/security
investorshub.advfn.com/Progressive-Care-Inc-RXMD-19843
$RXMD has been under attack for years, ever since the former CEO took action to force naked shorts to cover. IMO, it is the only reason that the PPS is so low.
Progressive Care Updates Shareholders on the Status of Naked Shorts
May 1, 2018.
https://www.globenewswire.com/news-release/2018/05/01/1494089/0/en/Progressive-Care-Updates-Shareholders-on-the-Status-of-Naked-Shorts.html
High Speed Trading Firm... going to war with the SEC
Message Board Thread
Good Luck RXMD!
$$$,$$$,$$$
Let's get $.05 today first.
$RXMD - BREAKOUTS 4 OF THE PAST 5 DAYS! UP OVER 200%%%%% STILL GOING UP!
$RXMD - BREAKOUTS 4 OF THE PAST 5 DAYS! UP OVER 200%%%%% STILL GOING UP!
$RXMD - LOOKING FOR $.25++++ TODAY! I WAS RIGHT FROM $.03 to $.18 IN THE LAST WEEK ALONE! IMO
Why not break them up in 100,000 or 250,000? Don't ruin the move upward with a big block. Not Smart also I wouldn't sell with S-1, Merger, and January Numbers coming anyday!
HUGE FINISH! $.30 SOON!
COMING UP ON 4 YEARS AUDITED FINANCIALS!!!
MERGER NEWS COMING SOON!!!
JANUARY NUMBERS COMING!!!
S-1 COMING!!!
$40.6 MILLION IN REV'S IN 2020 HERE FOLKS!!!!!!
KEEP OFF THE ASK!!! WE ARE SUPER THINNNNNNNN!!!!!!!!!!!!!!!
RXMD - Yes it is!!!
This is just the start here!!!!!!!!!!!
$.20's close today.....
$RXMD - UP 30% TODAY! OVER 150% PAST FEW DAYS! MERGER, S-1, AUDIT ALL COMING SOON!!!! NEW BASE FORMED AT $.17! UP FROM $.03!!!
$RXMD - UP 30% TODAY! OVER 150% PAST FEW DAYS! MERGER, S-1, AUDIT ALL COMING SOON!!!!
$RXMD =- UP 30% TODAY! OVER 150% PAST FEW DAYS! MERGER, S-1, AUDIT ALL COMING SOON!!!!
Once we get to COPPER I'll be very excited! No selling at this level!!!
I stated this a few weeks ago this is a long term hold and will fly!
S-1, January Numbers, Merger, Audit all to come soon!
POWER HOUR! THE PUSH TO $.20 HAS BEGUN!!! $.17's UP!
I still think $.18. We always have the afternoon push from outsiders.
Same. I have 3 accounts. 2 are ROTH's. I have decades for this to grow tax free!
Looking like $.17's might be the new base here....
Same here...waiting for the HUGE payday!!!
Nice Read! I'm more interested on what the barometer is at today!!!